Results 51 to 60 of about 2,302 (210)

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

, 2004
Background— Microalbuminuria is associated with increased risk of cardiovascular events. We assessed whether therapeutic intervention aimed at lowering urinary albumin excretion would reduce cardiovascular events in microalbuminuric subjects (15 to 300 ...
Asselbergs, Folkert, Diercks, G.F.H.; id_orcid, Hillege, Hans, Van Veldhuisen, D.J., Diercks, G.F.H., De Jong, P.E., de Zeeuw, Dick; id_orcid, van Boven, A.J., van Gilst, W.H., Janssen, W.M.T., Voors, Adriaan, de Zeeuw, Dick   +11 more
core   +1 more source

Impact of Renin–Angiotensin–Aldosterone System (RAAS) Gene Polymorphism in Essential Hypertension and Antihypertensive Drug Therapy: A Review

International Journal of Hypertension, Volume 2025, Issue 1, 2025.
Genetic, demographic and environmental factors all play a role in the frequency of an intricate multifactorial condition known as hypertension. Approximately 30% and 50% of BP fluctuation are influenced by genetic variability. Many genetic studies have confirmed the link between genetic variability and susceptibility to essential hypertension; hence ...
Archana Adhikari, Chandrakala Sharma, Mingma Lhamu Sherpa, Gauthaman Karaunakran, Mona Dhakal, Anita Sharma, Nidhi Chaudhary   +6 more
wiley   +1 more source

Docking Studies and Biological Activity of Fosinopril Analogs

, 2020
The purpose of the present study was to determine the angiotensin-I converting enzyme inhibitory activity of few novel Fosinopril derivatives which were predicted to possess better ACE inhibitory activity and lesser side effects than the existing drug ...
Maria Cristina Breschi, Suvarna G Kini, Jayant Choudary, Sreedhara Ranganath, Muhammad Mubeen, Pai Karkala   +5 more
core  

Polypharmacy and Potential Drug–Drug Interactions in Patients With Atrial Fibrillation

Journal of Clinical Pharmacy and Therapeutics, Volume 2025, Issue 1, 2025.
What is Known and Objective: The use of multiple medications, or polypharmacy, is associated with an elevated risk of potential drug–drug interactions (pDDIs), consequently heightening the probability of adverse drug reactions. Currently, there is a dearth of data regarding pDDIs in Chinese patients with atrial fibrillation (AF) within real‐world ...
Ying Bai, Jianqi Wang, Guangyao Li, Zhen Zhou, Nicholas B. Norgard   +4 more
wiley   +1 more source

A Clinical Study on the Anti-Hypertensive Efect of Fosinopril in Mild to Moderate Hypertensive Patients

, 1994
Background: The angiotensin-converting enzyme inhibitors have been found to be safe and efficacious in the treatment of essential hypertension. Fosinopril is the first angiotensin-converting enzyme inhibitor from a new class of agents containing ...
하종원
core   +1 more source

The Efficacy of Losartan Treatment in Hypertensive Type 2 Diabetic Patients

Endocrinology Research and Practice, 2022
The aim of this study is to evaluate the effects of losartan on hypertension, glomerular hyperfiltration and urinary albumin excretion, and also assess the metabolic changes in comparison with ACEI. Thirty three type 2 diabetic hypertensive patients were
Akif Şahin, Halil Kavgacı, Halil Önder Ersöz, Cihangir Erem   +3 more
doaj   +2 more sources

Rediscovery of the implication of albuminuria in heart failure: emerging classic index for cardiorenal interaction

ESC Heart Failure, Volume 11, Issue 6, Page 3470-3487, December 2024.
Abstract The development of new drugs and device therapies has led to remarkable advancements in heart failure (HF) treatment in the past couple of decades. However, it becomes increasingly evident that guideline‐directed medical therapy cannot be one‐size‐fits‐all across a wide range of ejection fractions (EFs) and various aetiologies.
Kyung‐Duk Min, Yuki Matsumoto, Masanori Asakura, Masaharu Ishihara   +3 more
wiley   +1 more source

Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure

ESC Heart Failure, Volume 11, Issue 6, Page 3862-3871, December 2024.
Abstract Aims Limited data are available that evaluate the efficacy of renin‐angiotensin system inhibitor (RASI) dose‐reduction in older adults with heart failure with reduced ejection fraction following a heart failure hospitalization. Methods and results We examined a 5% random sample of Medicare beneficiaries with prescription coverage who were ...
Parag Goyal, Ligong Chen, Jennifer D. Lau, Robert S. Rosenson, Emily B. Levitan   +4 more
wiley   +1 more source

Pilot trial of an electronic decision support to improve care for emergency department patients with acute heart failure

ESC Heart Failure, Volume 11, Issue 6, Page 4432-4436, December 2024.
Abstract Aims Emergency department (ED) providers play an important role in the management of patients with acute heart failure (AHF). We present findings from a pilot study of an electronic decision support that includes personalized risk estimates using the STRIDE‐HF risk tool and tailored recommendations for initiating guideline directed medical ...
Dana R. Sax, Dustin G. Mark, Jamal S. Rana, Jie Huang, Scott D. Casey, Robert P. Norris, Viliami Tillage, Mary E. Reed   +7 more
wiley   +1 more source

Fosinopril – characteristics and use

, 2011
ACE-inhibitori mogu se razlikovati prema učinkovitosti, lipofilnosti, putevima eliminacije i vremenu poluizlučivanja, a također i prema osobitosti je li lijek aktivan sastojak ili zahtijeva metaboličku aktivaciju.
Delić-Brkljačić, Diana
core